What is Polycystic Metabolic Ovarian Syndrome (PMOS)? Professional Definition
Polycystic Metabolic Ovarian Syndrome (PMOS) is Renamed diagnostic term for PCOS emphasizing metabolic endocrine aspects This is a widely used professional term in related fields.
A comprehensive diagnostic reclassification of the condition previously known as Polycystic Ovary Syndrome (PCOS), officially adopted by the International Federation of Gynecology and Obstetrics (FIGO) in 2026. The new name “Polycystic Metabolic Ovarian Syndrome” better reflects the condition’s systemic nature, encompassing not just ovarian cysts but a complex interplay of endocrine, metabolic, and reproductive abnormalities. PMOS is characterized by hyperandrogenism, ovulatory dysfunction, polycystic ovarian morphology, insulin resistance, and increased risk of type 2 diabetes, cardiovascular disease, and mental health disorders. The reclassification aims to improve diagnostic accuracy, reduce stigma associated with the term “cyst,” and promote a multidisciplinary treatment approach addressing both reproductive and metabolic health. Medical guidelines now recommend comprehensive metabolic screening for all PMOS patients, including glucose tolerance testing, lipid profile analysis, and cardiovascular risk assessment.
Frequently Asked Questions
- Q: Which medical fields use this term?
A: It is applied in clinical treatment, pharmacy and health examination. - Q: How is this term used in medical diagnosis?
A: It helps doctors describe symptoms, conditions and medical standards. - Q: Why is this medical term necessary?
A: It ensures accurate communication between medical staff and patients.
Reference Source: Polycystic Metabolic Ovarian Syndrome (PMOS) Official Document